Abstract
BackgroundAdoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) has shown great benefit in patients with melanoma.1,2 It was suggested that long term tumor immunosurveillance is provided by TIL persisting...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have